20.97
price up icon0.43%   0.09
after-market アフターアワーズ: 20.97
loading

なぜStevanato Group Spa(STVN)の株価が下がっていますか?

2025-03-25 の取引セッション中に、Stevanato Group Spa (STVN) 株の 5.55% 下落を確認しました。これは通常のボラティリティやさまざまな内部および外部要因に起因する可能性がありますが、当社では状況を積極的に監視しており、できるだけ早くタイムリーな最新情報を提供することに注意してください。
2024-03-20:

Stevanato Group (STVN) stock dropped by 5.25% following the announcement by Stevanato Group S.p.A. of an underwritten public offering of its ordinary shares. Stevanato Group is a prominent global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries.

  • Offering Details: The offering consists of $150,000,000 of ordinary shares from Stevanato Group (the “Company Offering”) and $150,000,000 from Stevanato Holding S.r.l., a major shareholder of the Company (the “Selling Shareholder Offering”). The Selling Shareholder currently holds approximately 78% of Stevanato Group’s outstanding ordinary shares. Additionally, the underwriters have the option to purchase additional ordinary shares up to 15% of the aggregate number of shares offered in the Offering.
  • Impact on Stock Price: The drop in Stevanato Group's stock price can be attributed to the dilution effect caused by the offering of additional shares. When a company issues new shares, it increases the total number of shares outstanding, diluting the ownership stake of existing shareholders. This can lead to a decrease in the stock price as the market adjusts to the increased supply of shares. Additionally, investors may interpret the offering as a signal that the company is in need of capital, which could raise concerns about its financial health or future growth prospects, further impacting the stock price.
$163.98
price up icon 3.73%
$76.62
price up icon 0.37%
$60.56
price down icon 1.34%
medical_instruments_supplies WST
$221.50
price up icon 0.61%
medical_instruments_supplies COO
$81.23
price down icon 0.05%
medical_instruments_supplies BAX
$33.65
price down icon 1.09%
大文字化:     |  ボリューム (24 時間):